Current Value of Holding

$111 Thousand

Shares

38 Thousand

% of Portfolio

0.00%

Average Buy Price

$13.1

Avg closing price
Price range

12 Ken Griffin Protara Therapeutics Trades

Ken Griffin acquired 38 Thousand Protara Therapeutics shares worth $111 Thousand. That's 0.00% of their equity portfolio (4325th largest holding). The first Protara Therapeutics trade was made in Q1 2021. Since then Ken Griffin bought shares six more times and sold shares on five occasions. The investor's estimated purchase price is $497 Thousand, resulting in a loss of 78%.

Avg closing price
Price range
Increased shares by 71.8% (+15.9 Thousand shares) Q4 2023
Avg closing price $1.47
Price range $1.12 - $1.93
Increased shares by 121.3% (+12.1 Thousand shares) Q3 2023
Avg closing price $2.29
Price range $1.64 - $2.93
Sold 78.3% shares (-36.2 Thousand shares) Q2 2023
Avg closing price $2.97
Price range $2.27 - $3.59
Increased shares by 211.1% (+31.3 Thousand shares) Q1 2023
Avg closing price $3.30
Price range $2.76 - $3.91
Sold 91.3% shares (-156 Thousand shares) Q4 2022
Avg closing price $3.16
Price range $2.43 - $3.70
Sold 29.7% shares (-72 Thousand shares) Q3 2022
Avg closing price $3.39
Price range $2.96 - $4.27
Sold 40.3% shares (-164 Thousand shares) Q2 2022
Avg closing price $3.66
Price range $2.80 - $5.33
Sold 5.2% shares (-22.1 Thousand shares) Q1 2022
Avg closing price $5.26
Price range $4.19 - $6.90
Increased shares by 23.7% (+81.9 Thousand shares) Q4 2021
Avg closing price $6.89
Price range $6.15 - $7.76
Increased shares by 1.3% (+4.41 Thousand shares) Q3 2021
Avg closing price $7.80
Price range $6.38 - $9.30
Increased shares by 41.6% (+101 Thousand shares) Q2 2021
Avg closing price $11.33
Price range $8.68 - $16.99
New holding (+242 Thousand shares) Q1 2021
Avg closing price $18.54
Price range $13.75 - $23.86

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!